SA515370289B1 - طريقة وجهاز لتوفير نظام تجريع عقار دوائي حركي - Google Patents
طريقة وجهاز لتوفير نظام تجريع عقار دوائي حركيInfo
- Publication number
- SA515370289B1 SA515370289B1 SA515370289A SA515370289A SA515370289B1 SA 515370289 B1 SA515370289 B1 SA 515370289B1 SA 515370289 A SA515370289 A SA 515370289A SA 515370289 A SA515370289 A SA 515370289A SA 515370289 B1 SA515370289 B1 SA 515370289B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- dosing regime
- dosing
- providing
- regime
- plasma protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/50—Mutagenesis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/20—Probabilistic models
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Data Mining & Analysis (AREA)
- Primary Health Care (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Computing Systems (AREA)
- Databases & Information Systems (AREA)
- Physiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioethics (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Probability & Statistics with Applications (AREA)
Abstract
يتعلق الاختراع الحالي بنظام وطريقة لتوفير نظام تجريع بروتين بلازما علاجي (therapeutic plasma protein dosing regimen) تتضمن تحديد، من خلال معالج (processor)، نمط دوائي حركي (pharmacokinetic profile) مُقدّر لمريض باستخدام نموذج Bayesian للأنماط الدوائية الحركية (pharmacokinetic profiles) من مرضى تم أخذ العينات منهم. تتضمن أيضا الطريقة والنظام التمثيليين تحديد نظام تجريع (dosing regimen) أول من أجل فاصل زمني لتجريع (dosing interval) محدد أول يتضمن (1) تجريع أول و(2) مستوى بروتين بلازما علاجي (therapeutic plasma protein) أول في المريض بمرور فترة زمنية اعتمادا على الأقل على النمط الدوائي الحركي (pharmacokinetic profile) وتحديد نظام تجريع (dosing regimen) ثان من أجل فاصل زمني لتجريع (dosing interval) محدد ثان يتضمن (1) تجريع ثان و(2) مستوى بروتين بلازما علاجي (therapeutic plasma protein) ثان في المريض بمرور فترة زمنية اعتمادا على الأقل على النمط الدوائي الحركي (pharmacokinetic profile). تتضمن إضافيا الطريقة والنظام التمثيليين عرض نظام التجريع (dosing regimen) الأول ونظام التجريع (dosing regi
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361837421P | 2013-06-20 | 2013-06-20 | |
US201361840969P | 2013-06-28 | 2013-06-28 | |
US201361881214P | 2013-09-23 | 2013-09-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
SA515370289B1 true SA515370289B1 (ar) | 2022-02-02 |
Family
ID=52111779
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SA521430246A SA521430246B1 (ar) | 2013-06-20 | 2015-12-17 | طريقة وجهاز لتوفير نظام تجريع عقار دوائي حركي |
SA515370289A SA515370289B1 (ar) | 2013-06-20 | 2015-12-17 | طريقة وجهاز لتوفير نظام تجريع عقار دوائي حركي |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SA521430246A SA521430246B1 (ar) | 2013-06-20 | 2015-12-17 | طريقة وجهاز لتوفير نظام تجريع عقار دوائي حركي |
Country Status (23)
Country | Link |
---|---|
US (1) | US20140379629A1 (ar) |
EP (3) | EP3010681B1 (ar) |
JP (4) | JP2016526542A (ar) |
KR (4) | KR102296042B1 (ar) |
CN (2) | CN111508557B (ar) |
AU (3) | AU2014287706B2 (ar) |
BR (3) | BR122022000127A8 (ar) |
CA (1) | CA2915472C (ar) |
CL (1) | CL2015003641A1 (ar) |
EA (1) | EA037962B1 (ar) |
ES (1) | ES2882832T3 (ar) |
GE (2) | GEP20186882B (ar) |
IL (3) | IL279313B (ar) |
MX (3) | MX2015017878A (ar) |
MY (2) | MY176173A (ar) |
NZ (1) | NZ715216A (ar) |
PH (1) | PH12015502800B1 (ar) |
PL (1) | PL3010681T3 (ar) |
SA (2) | SA521430246B1 (ar) |
SG (1) | SG11201510515YA (ar) |
UA (1) | UA118109C2 (ar) |
WO (1) | WO2015006033A1 (ar) |
ZA (1) | ZA201600100B (ar) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103987321B (zh) * | 2011-12-13 | 2017-06-09 | 皇家飞利浦有限公司 | 用于基于结果质量的剂量优化的系统和方法 |
KR102370479B1 (ko) | 2012-10-05 | 2022-03-04 | 다이앤 몰드 | 수학적 모형 함수로서의 환자-특이적 투여법용 의약 |
ES2967617T3 (es) * | 2013-12-06 | 2024-05-03 | Bioverativ Therapeutics Inc | Herramientas de farmacocinética poblacional y sus usos |
WO2015154090A1 (en) | 2014-04-04 | 2015-10-08 | Bloodworks | Routine laboratory and point-of-care (poc) testing for hemostasis |
US11062797B2 (en) * | 2014-10-10 | 2021-07-13 | Continuous Precision Medicine | Method and system for obtaining and using pharmacokinetic data in drug administration |
SG10202009369SA (en) * | 2015-04-09 | 2020-10-29 | Diane Mould | Systems and methods for patient-specific dosing |
WO2017136583A1 (en) * | 2016-02-02 | 2017-08-10 | Versartis, Inc. | Growth hormone treatment adherence system |
CA3020346A1 (en) * | 2016-04-15 | 2017-10-19 | Baxalta Incorporated | Method and apparatus for providing a pharmacokinetic drug dosing regimen |
JP6807015B2 (ja) * | 2016-06-13 | 2021-01-06 | ソニー株式会社 | 情報処理装置、情報処理方法、およびプログラム |
US10896749B2 (en) * | 2017-01-27 | 2021-01-19 | Shire Human Genetic Therapies, Inc. | Drug monitoring tool |
US20190365317A1 (en) * | 2017-02-01 | 2019-12-05 | Shire Human Genetic Therapies, Inc. | Physiological sensing and therapeutic administration system and method |
BE1027052A1 (fr) | 2019-02-14 | 2020-09-07 | Aardex Group | Procede d'assistance a la prise ou a l'acte d'un traitement therapeutique |
US10970651B1 (en) * | 2019-12-02 | 2021-04-06 | Sas Institute Inc. | Analytic system for two-stage interactive graphical model selection |
KR102420872B1 (ko) * | 2020-12-18 | 2022-07-14 | 포항공과대학교 산학협력단 | 강화학습과 약동-약력학 모델을 이용한 연속 약물 투여량 결정 방법 |
CN113053508A (zh) * | 2021-03-29 | 2021-06-29 | 深圳市科曼医疗设备有限公司 | 基于触控屏的交互控制方法及装置 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07124125A (ja) * | 1993-11-04 | 1995-05-16 | S R L:Kk | 薬物投与解析システム |
HUP9700603A3 (en) * | 1996-03-20 | 2001-08-28 | Baxter Ag | Pharmaceutical preparation for the treatment of blood coagulation disorders |
AU5219798A (en) * | 1996-12-09 | 1998-07-03 | Samuel David | Gpi-ceruloplasmin, analogs thereof, and methods of use |
BR0010316A (pt) * | 1999-05-11 | 2004-04-27 | Ortho Mcnell Pharmaceutical In | Método e sistema para obtenção de regimes de dosagem otimizados de epo para uma resposta farmacodinâmica/farmacocinética desejada em um paciente |
US7860583B2 (en) * | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
JP2004510961A (ja) * | 2000-09-15 | 2004-04-08 | ビルコ・ビーブイビーエイ | 疾患の処置のための薬物療法を最適化するシステムおよび方法 |
AU2004209286B2 (en) * | 2003-02-01 | 2009-01-08 | Baxter International Inc. | Wireless medical data communication system and method |
EP1642607A1 (en) * | 2004-10-04 | 2006-04-05 | Sanofi-Aventis Deutschland GmbH | Dose display mechanism for a drug delivery device |
JP2006155071A (ja) * | 2004-11-26 | 2006-06-15 | Toshiba Sumiden Medical Information Systems Corp | 電子カルテ薬物療法指示実施システム |
US20060183786A1 (en) * | 2005-02-16 | 2006-08-17 | Chi Mei Foundation Hospital | Injectable long-acting analgesic composition comprising an ester derivative of ketorolac |
CA2911569C (en) * | 2005-11-29 | 2019-11-26 | Children's Hospital Medical Center | Optimization and individualization of medication selection and dosing |
EP2286359A2 (en) * | 2008-03-27 | 2011-02-23 | Medtronic, Inc. | Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools |
US8591454B2 (en) * | 2008-11-10 | 2013-11-26 | The Invention Science Fund I, Llc | Administering a therapeutic agent with more than one taggant |
SG181130A1 (en) | 2009-12-06 | 2012-07-30 | Biogen Idec Hemophilia Inc | Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof |
-
2014
- 2014-06-20 EP EP14823224.2A patent/EP3010681B1/en active Active
- 2014-06-20 GE GEAP201414039A patent/GEP20186882B/en unknown
- 2014-06-20 JP JP2016521871A patent/JP2016526542A/ja active Pending
- 2014-06-20 GE GEAP201414559A patent/GEP20196990B/en unknown
- 2014-06-20 WO PCT/US2014/043517 patent/WO2015006033A1/en active Application Filing
- 2014-06-20 PL PL14823224T patent/PL3010681T3/pl unknown
- 2014-06-20 EA EA201690048A patent/EA037962B1/ru unknown
- 2014-06-20 CN CN202010499366.3A patent/CN111508557B/zh active Active
- 2014-06-20 CA CA2915472A patent/CA2915472C/en active Active
- 2014-06-20 BR BR122022000127A patent/BR122022000127A8/pt not_active Application Discontinuation
- 2014-06-20 MY MYPI2015704622A patent/MY176173A/en unknown
- 2014-06-20 AU AU2014287706A patent/AU2014287706B2/en active Active
- 2014-06-20 NZ NZ715216A patent/NZ715216A/en unknown
- 2014-06-20 KR KR1020167001142A patent/KR102296042B1/ko active IP Right Grant
- 2014-06-20 EP EP21170633.8A patent/EP3879534A1/en active Pending
- 2014-06-20 UA UAA201600443A patent/UA118109C2/uk unknown
- 2014-06-20 KR KR1020217026984A patent/KR102352133B1/ko active IP Right Grant
- 2014-06-20 KR KR1020227015723A patent/KR20220065097A/ko not_active Application Discontinuation
- 2014-06-20 IL IL279313A patent/IL279313B/en unknown
- 2014-06-20 EP EP17197995.8A patent/EP3309696A1/en not_active Withdrawn
- 2014-06-20 BR BR112015031856A patent/BR112015031856A8/pt not_active Application Discontinuation
- 2014-06-20 US US14/311,113 patent/US20140379629A1/en not_active Abandoned
- 2014-06-20 SG SG11201510515YA patent/SG11201510515YA/en unknown
- 2014-06-20 KR KR1020227001162A patent/KR102397974B1/ko active IP Right Grant
- 2014-06-20 CN CN201480046279.5A patent/CN105592973B/zh active Active
- 2014-06-20 MX MX2015017878A patent/MX2015017878A/es active IP Right Grant
- 2014-06-20 ES ES14823224T patent/ES2882832T3/es active Active
- 2014-06-20 BR BR122020013811A patent/BR122020013811A8/pt not_active Application Discontinuation
- 2014-06-20 MY MYPI2020003916A patent/MY195911A/en unknown
-
2015
- 2015-12-16 CL CL2015003641A patent/CL2015003641A1/es unknown
- 2015-12-16 PH PH12015502800A patent/PH12015502800B1/en unknown
- 2015-12-17 IL IL243208A patent/IL243208B/en active IP Right Grant
- 2015-12-17 SA SA521430246A patent/SA521430246B1/ar unknown
- 2015-12-17 SA SA515370289A patent/SA515370289B1/ar unknown
- 2015-12-18 MX MX2020004112A patent/MX2020004112A/es unknown
- 2015-12-18 MX MX2023000359A patent/MX2023000359A/es unknown
-
2016
- 2016-01-06 ZA ZA2016/00100A patent/ZA201600100B/en unknown
-
2017
- 2017-12-07 AU AU2017272293A patent/AU2017272293B2/en active Active
-
2019
- 2019-05-22 JP JP2019095949A patent/JP6813237B2/ja active Active
-
2020
- 2020-04-21 AU AU2020202664A patent/AU2020202664B2/en active Active
- 2020-05-21 IL IL274848A patent/IL274848A/en active IP Right Grant
- 2020-12-11 JP JP2020205945A patent/JP7060291B2/ja active Active
-
2022
- 2022-04-11 JP JP2022065039A patent/JP7398031B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2017272293B2 (en) | Providing a pharmacokinetic drug dosing regimen | |
IN2015DN03826A (ar) | ||
EP3581226A3 (en) | Systems for delivery of therapeutic gas | |
MX2022012914A (es) | Dispositivos y metodos para administracion y mezcla de farmaco, y entrenamiento de tecnicas apropiadas para ello. | |
MX2018013503A (es) | Aparatos, métodos y sistemas para administrar medicamento utilizando kits de medicamento. | |
MX2020001369A (es) | Sistema de analisis para el cuidado de un paciente. | |
Requena et al. | Melomics music medicine (M 3) to lessen pain perception during pediatric prick test procedure. | |
SG11202106928PA (en) | Medicine administering device and medicine administering system | |
MX2017008000A (es) | Sistema de inyeccion de un solo uso. | |
EP3603709A4 (en) | LIQUID MEDICINE ADMINISTRATION DEVICE AND ITS OPERATING PROCEDURE | |
MX2016000103A (es) | Dispositivo de administracion de farmaco oral y metodos de uso del mismo. | |
BR112017022984A2 (pt) | dispositivo para facilitar o posicionamento de um cateter para administrar um medicamento em um paciente que esteja respirando espontaneamente | |
EA202190596A2 (ru) | Предоставление фармакокинетической схемы дозирования лекарственного средства | |
SG10201809418VA (en) | New administration routes of insulin, insulin analogs or derivatives of insulin | |
MA38685A1 (fr) | Fourniture d'un régime de dosage de médicament pharmacocinétique | |
WO2016077565A3 (en) | Methods for chronic pain management and treatment using hcg | |
TH160649B (th) | เครื่องและวิธีการสำหรับข้อกำหนดการให้ขนาดยาทางเภสัชจลนศาสตร์ | |
TH160649A (th) | เครื่องและวิธีการสำหรับข้อกำหนดการให้ขนาดยาทางเภสัชจลนศาสตร์ | |
EP3925646A4 (en) | LIQUID MEDICATION ADMINISTRATION DEVICE AND KIT | |
Vinas | Cetirizine/hydroxyzine | |
Ramatillah et al. | MANAGEMENT OF PAIN TREATMENT FOR POST ABDOMEN SURGERY PATIENTS FROM JANUARY TO MARCH 2015 IN ISLAMIC HOSPITAL CEMPAKA PUTIH, JAKARTA | |
MX2019004394A (es) | Dispositivo para facilitar la administracion de un medicamento al pulmon por un cateter. | |
EP3646907A4 (en) | DEVICE FOR ADMINISTRATING LIQUID MEDICATION AND METHOD FOR PRODUCING A DEVICE FOR ADMINISTRATING LIQUID MEDICATION | |
林彤 et al. | Clinical Outcome of in Vitro Fertilization-embryo Transfer in Patients Over 40 Years from a Single Institution in Guangdong, China |